Bioclinica

BioClinica, now known as Clario, is a pioneering company resulting from the merger of ERT and Bioclinica, two global leaders in clinical endpoint technology and medical imaging, respectively. Founded in 1998 and headquartered in the United States, Clario is dedicated to creating the most comprehensive clinical evidence by combining scientific expertise and global reach through its broad endpoint technology platform. This approach allows Clario to empower its partners in making transformative impacts on people's lives. With a focus on Biotechnology, the company is committed to driving innovation in clinical trials through technology and striving to have a positive influence on global healthcare.

The most recent investment came in the form of a Venture Round in January 2013, with support from SV Health Investors. This investment further solidified Clario’s position as a leading force in the industry, allowing it to continue its mission of leveraging technology to advance the future of clinical trials and contribute to positive changes in the healthcare landscape.